Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
2022 · The Lancet · 395 citations
https://doi.org/10.1016/s0140-6736(22)00519-0
M
Matthias Hoffmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
179
Papers
6.3K
Citations
37
h-index
97
i10-index
Matthias Hoffmann is an academic researcher from Kantonsschule Olten. The author has contributed to research in topics: HIV Research and Treatment & HIV/AIDS Research and Interventions & Immune Cell Function and Interaction. The author has an h-index of 37, co-authored 153 publications.
ORCID: 0000-0002-8764-6861Papers by this author
worksImmunological biomarkers predict HIV-1 viral rebound after treatment interruption
2015 · Nature Communications · 173 citations
https://doi.org/10.1038/ncomms9495
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
2011 · BMC Infectious Diseases · 32 citations
https://doi.org/10.1186/1471-2334-11-319
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
2024 · Clinical Infectious Diseases · 25 citations
https://doi.org/10.1093/cid/ciae228
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland
2016 · Scientific Reports · 16 citations
https://doi.org/10.1038/srep27580
Littoral cell angioma of the spleen in a patient with previous pulmonary sarcoidosis: a TNF-α related pathogenesis?
2011 · World Journal of Surgical Oncology · 15 citations
https://doi.org/10.1186/1477-7819-9-106
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat